Global leader in Data-Driven Medicine, SOPHiA GENETICS is a health tech company which has developed SOPHiA AI, the most advanced technology for clinical genomics, helping healthcare professionals better diagnose and treat patients.
The global network of over 850 institutions from 77 countries that use the SOPHiA DDM analytical platform powered by SOPHiA form the world’s largest clinical genomics community.
By enabling the rapid adoption of genomic testing worldwide, turning data into actionable clinical insights, and sharing knowledge through its community, SOPHiA GENETICS is democratizing Data-Driven Medicine to help save lives.
|Jan 4, 2019||
Series E – Sophia Genetics
|4||$77M||Generation Investment Management|
|Sep 13, 2017||
Series D – Sophia Genetics
|Dec 16, 2015||
Series C – Sophia Genetics
|Jul 7, 2014||
Series B – Sophia Genetics
|3||$13.8M||Invoke Capital Partners|
|Dec 17, 2013||
Venture Round – Sophia Genetics
The greatest minds from around the world in genomics, bioinformatics, artificial intelligence and data privacy are all working towards this shared goal continuously honing technologies, improving offers and expanding services for the benefits of researchers. About 80% of our organization holds a PhD, ranging from Molecular Biology to Computer Science. This international and dedicated team is the key to democratizing Data-Driven Medicine worldwide.
Chief Executive Officer and Co-founder
SVP – Genomics Business Area
SVP – Radiomics Business Area
SVP – Clinical Trials Business Area
SVP – Chief Commercial Officer
SVP – Chief Financial Officer
SVP – Chief Information Officer
SVP – Chief Platform Officer
General Manager North America
SVP – Chief Technology Officer
TRUSTED BY OVER 850 HOSPITALS WORLDWIDE
Visited 26 times, 1 Visit today